USE OF SERUM AMYLOID A GENE IN DIAGNOSIS AND TREATMENT OF GLAUCOMA AND INDENTIFICATION OF ANTI-GLAUCOMA AGENTS
Application 2385/DELNP/2006 published 2007-08-03, filed 2006-04-28
The present invention provides compositions and methods for treating glaucoma, methods for diagnosing glaucoma, and methods for identifying agents which may be useful in the treatment of glaucoma. More specifically, the present invention describes the use of agents that modulate the expression of serum amyloid A.
Applicant
1)ALCON, INC.
:BOSCH 69, P.O. BOX 62,CH-8331 HUNENBERG, SWITZERLAND. Switzerland
Inventor
1)CLARK, ABBOT F. 2)WANG, WAN-HENG 3)McNATT, LORETTA
International Info
Classification: A61K
Publication Number: WO 2005/060542
Application Date: 2004-12-01
Priority Information
60/530,430 U.S.A. 2003-12-17